Found: 7
Select item for more details and to access through your institution.
Long term complete response of advanced hepatocellular carcinoma to glypican-3 specific chimeric antigen receptor T-Cells plus sorafenib, a case report.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.963031
- By:
- Publication type:
- Article
EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0704-x
- By:
- Publication type:
- Article
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 475, doi. 10.1007/s00262-016-1949-8
- By:
- Publication type:
- Article
Identification and characterization of Ch806 mimotopes.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1481, doi. 10.1007/s00262-010-0872-7
- By:
- Publication type:
- Article
Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2008, v. 40, n. 3, p. 217, doi. 10.1111/j.1745-7270.2008.00389.x
- By:
- Publication type:
- Article
Loan guarantees and SMEs' investments under asymmetric information and Bayesian learning.
- Published in:
- Journal of Risk & Insurance, 2024, v. 91, n. 3, p. 567, doi. 10.1111/jori.12485
- By:
- Publication type:
- Article
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article